TLR4 and neoplasm: Tumor-derived sCRT39-272 should be able to help sustaining such an inflammatory microenvironment because of its potent ability to elicit proinflammatory cytokine production by monocytes/macrophages via CD14/TLR4 as documented by our previous work (14, 15).